venBio Partners LLC

Q2 2026 13F-HR Holdings

Location
San Francisco, CA
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
7
Total value ($000)
$519,380
Net value change ($000)
+238,827 (85.1%)
New positions
2
Sold out positions
1
Turnover %
35.8%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
PARABILIS MEDICINES INC 144,149 NEW
ACHV 38,623 NEW
PHVS 29,510 22.5%
ALMS 27,668 27.7%
HRMY 3,491 25.5%
ALXO 837 3.2%
Top Reduces (Value $000, Stocks/ETFs)
ARTV -3,422 -100.0%
LYEL -2,029 -30.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type